China Ophthalmic Hospital Industry Report, 2012-2015
  • May.2013
  • Hard Copy
  • USD $1,600
  • Pages:51
  • Single User License
    (PDF Unprintable)       
  • USD $1,500
  • Code: XJT032
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,300
  • Hard Copy + Single User License
  • USD $1,800
With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, with an AAGR of 7.1% during 2006-2011; industry revenue attained to RMB6.0515 billion, with a CAGR of 24.8% during 2006-2011. Following the rising demand, the total revenue of ophthalmic hospitals in future is still expected to grow at a rate of more than 20%.

Total Revenue of China Ophthalmic Hospital Industry, 2006-2015E

Among Chinese specialized hospital market segments, ophthalmic hospital enjoys higher level of technology and profit, i.e. gross profit hit RMB892.4 million in 2011, with a compound growth rate of 49.1% in 2006-2011; gross margin was 14.7%, much higher than 3.8% of the hospital industry. Due to the uneven medical level as well as the quite different reception capabilities of eye care institutions, there are some differences in the level of profitability. China’s largest eye institution - Aier Ophthalmology, for instance, reached gross margin of about 50.0% in 2008-2012, significantly higher than the industrial average.

As there exists certain service radius, China’s eye care service industry shows an obvious competition pattern of “national dispersion, regional concentration”. With respect to the current market share, Eye & ENT Hospital of Fudan University, Zhongshan Ophthalmic Center of Sun Yat-sen University and other public ophthalmic hospitals hold greater market shares locally; private hospitals such as Aier Ophthalmology and Bright Eye Hospital are rapidly expanding the chain of eye care services, accompanied by an increasing market share on a national scale.

China Ophthalmic Hospital Industry Report, 2012-2015 mainly covers the followings:

20120114.gif?Overview of ophthalmic hospital market in China, including changes in number, operation, current medical services, competition pattern, etc. of ophthalmic hospitals;
20120114.gif?Environment for the development of ophthalmic hospitals in China, involving regulatory system, industry policies, related policies that encourage the entry of private capital, upstream & downstream industry and impact, etc.;
20120114.gif?China ophthalmic hospital industry growth forecast, including the influence of Taiwan’s “Seal Knife Gate” on the industry, ophthalmic medical institution market size forecast, investment opportunities and risks for private ophthalmic hospitals, etc.;
20120114.gif?Operation, investment, merger & acquisition, development forecast concerning three major private hospitals, two Sino-foreign hospitals and six public hospitals in China.

1. Overview of Ophthalmic Hospital Industry in China
1.1 Definition
1.2 Main Business
1.3 Industry Characteristics

2. Overview of Ophthalmic Hospital Market in China
2.1 Number of Hospitals
2.1.1 Stable Growth in the Number of Hospitals
2.1.2 Faster Growth of Non-public Hospitals
2.2 Revenue
2.3 Profit Level
2.4 Medical Service
2.5 Competition Pattern
2.6 Barriers to Entry
2.6.1 Market Access
2.6.2 Medical Personnel
2.6.3 Industry Experience & Management Level
2.6.4 Capital Strength

3. Development Environment 
3.1 Policy Environment 
3.1.1 Industry Regulation
3.1.2 Industry Policy 
3.2 Upstream & Downstream Sectors
3.2.1 Upstream 
3.2.2 Downstream

4. Investment Analysis
4.1 “Seal Knife Gate” Impact Dissipates
4.1.1 “Seal Knife Gate” Event
4.1.2 “Seal Knife Gate” Impact 
4.1.3 Industry Will Be Integrated
4.2 Eye Care Market Forecast
4.2.1 Excimer Laser Surgery
4.2.2 Cataract Surgery
4.2.3 Potential Demand in Primary Market
4.2.4 Market Size Forecasting
4.3 Private Eye Hospitals Win Development Opportunities
4.3.1 Policy Support
4.3.2 Clear Competitive Edge
4.4 Ophthalmic Hospitals Have More Development Advantages 
4.5 Investment Risk
4.5.1 Medical
4.5.2 Social Cognition
4.5.3 Market Competition
4.5.4 Human Resources
4.5.5 Medical Service Price Volatility
4.5.6 Legal 

5. Major Hospitals 
5.1 Aier Ophthalmology
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Medical Business
5.1.6 Forecast & Outlook
5.2 BO-AI Medical Group of Ophthalmology
5.2.1 Profile
5.2.2 Development
5.3 Bright Eye Hospital
5.3.1 Profile
5.3.2 Development
5.4 Eyegood Ophthalmic
5.4.1 Profile
5.4.2 Development
5.5 Maige Ophthalmology
5.5.1 Profile
5.5.2 Development
5.6 Zhongshan Ophthalmic Center of Sun Yat-sen University
5.6.1 Profile
5.6.2 Development
5.7 Eye & ENT Hospital of Fudan University
5.7.1 Profile
5.7.2 Development
5.8 Xiamen Eye Center of Xiamen University
5.8.1 Profile
5.8.2 Development
5.9 Tianjin Eye Hospital
5.9.1 Profile
5.9.2 Development
5.10 The Affiliated Eye Hospital of Wenzhou Medical College
5.10.1 Profile
5.10.2 Development
5.11 Shanxi Eye Hospital
5.11.1 Profile
5.11.2 Development
Introduction to Main Business of Ophthalmic Hospitals in China
Number of Hospitals in China, 2006-2011
Number of Ophthalmic Hospitals in China and % in Total Number of Hospitals, 2006-2011
Number of Ophthalmic Hospitals in China (by Economic Type), 2006-2011
Total Revenue of China Ophthalmic Hospital Industry, 2006-2011
Gross Profit of China Ophthalmic Hospital Industry, 2006-2011
Average Gross Margin of Hospitals and Ophthalmic Hospitals in China, 2006-2011
Bed Occupancy Rate of Ophthalmic Hospitals in China, 2006-2011
Average Daily Outpatient Visits per Physician in Chinese Ophthalmic Hospitals, 2007-2011
Average Daily Hospital Beds per Physician in Chinese Ophthalmic Hospitals, 2007-2011
Policies on China’s Social Capital Entry into the Field of Medical Services, 2009-2012
Difference between Policies on Private Hospitals and Public Hospitals
Total Health Costs in China, 1980-2011
China’s Total Health Costs as a Percentage of GDP, 1985-2011
Total Expenditure on Health of Resident Individuals in China, 1980-2011
Per Capita Health Care Expenditure of Urban and Rural Residents in China, 1990-2011
Per Capita Health Care Expenditure of Urban and Rural Residents in China as a Percentage of Consumptive Expenditure, 1990-2011
Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households in China, 2006-2012
Health Insurance System Structure in China
Population Coverage of Health Insurance in China, 2005-2011
Total Coverage of Health Insurance in China, 2005-2011
China’s Population aged 60 and over as a Percentage of Total Population, 2007-2013
Refractive Surgery Procedures and Market Price
Total Revenue of China Ophthalmic Hospital Industry, 2006-2015E
Important Events that Encourage the Development of Private Hospitals in China
Principal-agent Chain of Public Hospitals in China
Per Capita Treatment Cost in Private & Public Hospitals, 2012
Comparison of Specialized Medical Service Projects 
Revenue and Net Income of Aier Ophthalmology, 2008-2012
Revenue of Aier Ophthalmology by Product, 2008-2012
Revenue of Aier Ophthalmology by Region, 2008-2012
Gross Margin of Aier Ophthalmology by Product, 2008-2012
Revenue and Net Income of Aier Ophthalmology, 2011-2015
Introduction to Main Operating Agencies of BO-AI Medical Group of Ophthalmology
Introduction to Main Operating Agencies of Bright Eye Hospital

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号